43 results
PRE 14A
iyzxfhuqm1ojfhoi8n1s
19 Oct 23
Preliminary proxy
5:18pm
8-K
EX-10.1
e7owjr364qww pb
6 Oct 23
Departure of Directors or Certain Officers
4:10pm
8-K
yplqdyot9iifu7
5 Sep 23
Termination of a Material Definitive Agreement
8:00am
DEFR14A
wnlip9cln
25 Oct 22
Revised proxy
5:27pm
D
thsagxqr3
7 Oct 22
$16.19 mm in equity / options / securities to be acquired, sold $6.65 mm, 5 investors
5:32pm
8-K
EX-4.1
knifrbuh
29 Sep 22
Anebulo Pharmaceuticals Announces $6.6 million Private Placement Financing
4:05pm
8-K
EX-10.1
ngzxg9hn9r3jco
24 May 22
Anebulo Pharmaceuticals Appoints Kenneth Cundy, Ph.D., as Chief Scientific Officer
4:05pm